ICN Pharmaceuticals Inc., a Costa Mesa drug...
- Share via
ICN Pharmaceuticals Inc., a Costa Mesa drug manufacturer and distributor, said it will sell $19.2 million in convertible bonds in Switzerland. The bond sale represents ICN’s first entry into the Swiss public capital market.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
